Exec Chat: Adaptive Biotechnologies Will Use T Cells To Spot Prior Infections, Including COVID-19
Adaptive chief medical officer Lance Baldo talked to Medtech Insight about the company's plans to detect prior infection using T-cells obtained from blood samples.
You may also be interested in...
23andMe is teaming up with blank check company VG Acquisition Corp to go public, making the move into personalized health care.
Stimdia is trying to restore respiratory function in ICU patients with phrenic nerve stimulation.
The $1.1bn acquisition of drug-eluting balloon developer MedAlliance will help Cordis return to its roots as an innovative leader in interventional cardiology.